Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dawnrays Pharmaceutical (Holdings) Ltd. has announced the resignation of its CEO, Mr. Wu Weixian, effective from 5:00 pm on 11 September 2024, due to his desire to focus on personal commitments. The company is actively seeking a replacement and will update shareholders and the Hong Kong Stock Exchange once a suitable candidate is found. The board extends its gratitude to Mr. Wu for his services during his tenure.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.